General Information
Revision date
2014-06-02
Product name
Buprenorphine Hydrochloride Injection
Product Synonyms
17-(cyclopropylmethyl)--(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6- methoxy--methyl-6,14-ethenomorphinan-7-methanol, hydrochloride [5, 7(S)]
Manufacturer Name
Hospira, Inc
Emergency telephone
800-424-9300, 1-703-527-3887, 61-290372994, 44-870-8200418
Icons in SDS
Company Information
company name
Hospira, Inc
GHS Information
Signal word
NA
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Buprenorphine Hydrochloride Injection is a solution containing buprenorphine hydrochloride, an opioid analgesic used for the relief of moderate to severe pain and as an adjunct to anesthesia. In the workplace, this material should be considered potentially irritating to skin, eyes, and respiratory and a potent drug with some potential for dermal absorption. In the U.S., this product is a Schedule III controlled Substance. Based on clinical use, potential target organs include the nervous system, cardiovascular system, respiratory system, gastrointestinal system, and eyes.
Hazard categories
Not Classified Not Classified Not Classified Not Classified
Hazard pictograms
NA
Signal word
NA
Hazard statements
NA
Prevention
Do not breathe vapor or spray. Wash hands thoroughly after handling.
Response
Get medical attention if you feel unwell. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists, get medical attention. 1
2.1 Classification of the substance or mixture
Physical Hazards Hazard Class Hazard Category Not Classified Health Hazards Hazard Class Hazard Category Not Classified Label Element(s) Pictogram
